Implementation of License of Aureus Pharma’s Knowledge Databases by GSK
News Feb 07, 2006
Researchers at GSK’s global research and development centers will gain access to Aureus’ Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and ADME/Drug-Drug Interactions.
In addition, GSK has licensed the recently released AurSCOPE Kinase product making it the first customer of this knowledge base which is of major importance for oncology and other diseases.
"AurSCOPE knowledge databases are comprised of detailed quantitative biological and chemical data," said Dr. Andre Michel, CEO of Aureus Pharma.
"With its unrivalled level of quality, Aureus Pharma’s knowledge driven discovery platform provides drug discovery teams with comprehensive information to accelerate both the drug discovery and development process."
"We are pleased that GSK has selected Aureus Pharma as their global solution provider of integrated knowledge databases."
The addition of a pharmaceutical R&D world leader, such as GSK, to Aureus’ growing list of customers is further confirmation that AurSCOPE is becoming accepted as the knowledge base of choice for pharmaceutical and biotechnology organizations.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019